Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Evaluate the Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01183143
What this trial is testing

Convenience and Safety of Assisted Reproductive Technology Procedures Using a Gonal-F Filled by Mass (Fbm) Liquid Formulation Applied by Pen for Ovulation Induction and In-vitro Fertilization

Who this might be right for
InfertilityOvulation InductionIn-Vitro Fertilization
Merck KGaA, Darmstadt, Germany 215
Large-scale testing (Phase 3)Looking for participantsNCT07502443
What this trial is testing

Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2

Who this might be right for
Narcolepsy Type 2
Alkermes, Inc. 176
Not applicableStudy completedNCT03371615
What this trial is testing

Evaluation of the Tolerance and Safety of a New Partly Fermented Anti-regurgitation Infant Formula

Who this might be right for
Regurgitation, Gastric
Nutricia Research 182
Large-scale testing (Phase 3)Study completedNCT02604017
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 Infection

Who this might be right for
Chronic Hepatitis CHepatitis C VirusHCV
AbbVie 703
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07239440
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing BT-1 and BT-2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Who this might be right for
Diabete Mellitus
Dong-A ST Co., Ltd. 288
Early research (Phase 1)Study completedNCT01007968
What this trial is testing

Pharmacokinetics and Safety of Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic Function

Who this might be right for
Advanced Solid Tumors
Novartis Pharmaceuticals 25
Not applicableStudy completedNCT04889950
What this trial is testing

Evaluate the Safety and Effectiveness of The Tixel Fractional System in the Treatment of Meibomian Gland Disfunction

Who this might be right for
Dry Eye SyndromesDry EyeMeibomian Gland Dysfunction
Novoxel Ltd. 30
Not applicableNot Yet RecruitingNCT06708650
What this trial is testing

Combination of SFRT, PD-L1 Inhibitor, and Anti-VEGF in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaRadiotherapyPD-1 Inhibitors
Guiping People's Hospital 50
Early research (Phase 1)Study completedNCT04531150
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of INV-101 in Healthy Male and Female Subjects

Who this might be right for
Pharmacokinetic
Inversago Pharma Inc. 40
Testing effectiveness (Phase 2)Looking for participantsNCT05803018
What this trial is testing

BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies

Who this might be right for
Gynecological Malignant TumorSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 38
Testing effectiveness (Phase 2)Looking for participantsNCT06214143
What this trial is testing

A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Shanghai Pharmaceuticals Holding Co., Ltd 68
Testing effectiveness (Phase 2)Study completedNCT00534625
What this trial is testing

Assessment of PFT, Safety, and PK of Zileuton Injection in Asthma Patients

Who this might be right for
Asthma
Critical Therapeutics 36
Not applicableLooking for participantsNCT03671889
What this trial is testing

ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease

Who this might be right for
Alzheimer Disease
InSightec 50
Early research (Phase 1)Study completedNCT02963389
What this trial is testing

Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim in Pediatric Solid Tumor/Lymphoma Patients

Who this might be right for
Solid TumorLymphoma
Dong-A ST Co., Ltd. 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT04821089
What this trial is testing

Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines

Who this might be right for
Moderate to Severe Upper Facial Lines
Ipsen 727
Large-scale testing (Phase 3)Study completedNCT00781391
What this trial is testing

Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation

Who this might be right for
StrokeAtrial FibrillationEmbolism
Daiichi Sankyo 21,105
Large-scale testing (Phase 3)Ended earlyNCT05788497
What this trial is testing

Efficacy and Safety of Hemorrane Plus Versus Hemorrane and Versus Placebo in Patients With Uncomplicated Haemorrhoids

Who this might be right for
Haemorrhoids Without Complication
Faes Farma, S.A. 21
Testing effectiveness (Phase 2)Study completedNCT02565810
What this trial is testing

An Multicentre Clinical Study to Evaluate the Usability and Safety of the Pre-filled Pen and Pre-filled Syringe of SB5 in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Samsung Bioepis Co., Ltd. 49
Testing effectiveness (Phase 2)Study completedNCT01740297
What this trial is testing

Ipilimumab With or Without Talimogene Laherparepvec in Unresected Melanoma

Who this might be right for
Melanoma
Amgen 217
Early research (Phase 1)Study completedNCT02496897
What this trial is testing

Phase I Safety and Immunogenicity of FP-02.2 in Chronic Hepatitis B

Who this might be right for
Hepatitis B
Altimmune, Inc. 61
Next Page